Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Uncover effective strategies to find cash for bills quickly. Ensure you have the funds needed to cover essential expenses.
24,104 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
A 63-year-old with $800,000 may only afford roughly $23,000 a year in real spending after taxes, premiums, and delaye...
Small-cap ETFs can boost growth, but choosing the right one matters. This guide breaks down ISCB and SCHA, showing ho...
A Nasdaq Top-30 ETF is concentrating exposure on the biggest tech names and has outpaced QQQ in the AI megacap swing....
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
December data show the fed's favored inflation gauge remaining hotter than expected, underscoring persistent price pr...
A growing chorus of fintech executives argues that stablecoins could finally bring speed and transparency to cross-bo...
As Vanguard S&P 500 ETF continues to grow wealth for long-term investors, retirees weigh its 1.1% yield against highe...
Grok AI’s forecast of a $40K Bitcoin price has ignited a fierce market debate. Analysts say the model’s ultra-bear ca...
A watchdog group warns that trump’s loss $1.7 trillion in tariff revenue may push U.S. debt toward $58 trillion by 20...
A top Nomura strategist says equities are priced for chaos, but the odds of a sweeping market crash remain low as dat...
UiPath shares fell about 6% after a strong earnings print, prompting analysts to debate whether the AI automation the...